Clinical Trial Update: Demonstrate the Bioequivalence of Interferon Beta-1a (INFB) Manufactured by Two Different Processes in Healthy Volunteers [Phase 1]

View source ↗

Summary

This Phase 1 trial in healthy volunteers evaluated the bioequivalence of interferon beta-1a produced by two different manufacturing processes. The sponsor is Bi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Interferon beta-1a (Interferon beta-1a)

Snippet

Sponsor: Biogen | Conditions: Multiple Sclerosis | Phase 1 | Status: COMPLETED